Stock Performance Overview
The share price of Mukka Proteins Ltd has been on a downward trajectory, falling by 0.21% on the latest trading day, slightly underperforming the Sensex’s 0.17% decline. Over the past week, the stock has lost 1.99%, while the Sensex declined by only 0.43%. The trend extends over longer periods with the stock posting a 4.30% loss in the last month compared to a 0.33% gain in the Sensex, and a 10.33% decline over three months against a 3.72% rise in the benchmark index.
Most notably, Mukka Proteins has delivered a negative return of 38.64% over the last year, in stark contrast to the Sensex’s 8.54% gain. Year-to-date, the stock is down 1.71%, while the Sensex has fallen 0.47%. The stock’s performance over three and five years remains flat at 0.00%, significantly underperforming the Sensex’s 41.60% and 73.87% gains respectively. Over a decade, the stock has not recorded any appreciable growth, while the Sensex surged by 240.17%.
The stock currently trades below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, underscoring the sustained bearish momentum.
Financial Health and Profitability Metrics
Mukka Proteins’ financial indicators reveal challenges in profitability and capital efficiency. The company’s average Return on Capital Employed (ROCE) stands at 9.16%, a figure that indicates limited profitability relative to the capital invested. This low ROCE is a key factor behind the company’s current market valuation and investor sentiment.
Debt servicing capacity remains a concern, with a high Debt to EBITDA ratio of 5.26 times. This elevated leverage ratio suggests that the company faces significant interest obligations relative to its earnings before interest, taxes, depreciation, and amortisation.
Net sales growth has been modest, with an annualised increase of 8.60% over the past five years, which may not be sufficient to support robust long-term expansion or improve financial stability.
From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!
- - Early turnaround signals
- - Explosive growth potential
- - Textile - Machinery recovery play
Position for Explosive Growth →
Recent Quarterly Results
The company has reported negative results for seven consecutive quarters, highlighting ongoing difficulties in maintaining profitability. Profit Before Tax excluding Other Income (PBT LESS OI) for the latest quarter stood at Rs.3.28 crores, representing a sharp decline of 67.9% compared to the average of the previous four quarters.
Net Profit After Tax (PAT) for the quarter was Rs.5.88 crores, down 45.9% versus the prior four-quarter average. Interest expenses reached a peak of Rs.12.82 crores, further pressuring the company’s earnings and cash flow.
Institutional Investor Activity
Institutional investors have reduced their holdings by 0.6% in the most recent quarter, now collectively owning 3.36% of the company’s shares. This decline in institutional participation may reflect a reassessment of the company’s fundamentals by investors with greater analytical resources.
Long-Term and Sector Comparison
Over the last three years, Mukka Proteins has underperformed the BSE500 index, mirroring its one-year and three-month underperformance relative to broader market indices. Despite this, the company has demonstrated healthy growth in operating profit, which has increased at an annual rate of 50.86%, indicating some operational areas of strength.
The stock’s valuation metrics suggest it is trading at a discount compared to its peers’ historical averages. The Enterprise Value to Capital Employed ratio stands at a low 1.3, which may reflect market caution given the company’s financial profile and recent results.
Holding Mukka Proteins Ltd from FMCG? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Valuation and Profitability Context
While Mukka Proteins’ ROCE remains modest at 9.2%, the company’s valuation appears attractive relative to its capital employed. However, the stock’s recent price decline of 38.64% over the past year coincides with a 34% fall in profits, underscoring the challenges faced in translating operational performance into shareholder returns.
The company’s market capitalisation grade is rated 4, reflecting its current standing in the market, while the overall Mojo Score is 31.0 with a Sell grade, recently downgraded from Strong Sell on 14 Nov 2025. This grading reflects the comprehensive assessment of financial health, market performance, and risk factors.
Summary of Key Metrics
Mukka Proteins Ltd’s stock has experienced a sustained decline, culminating in a new all-time low of Rs.23.2. The company’s financial indicators reveal low capital efficiency, high leverage, and declining profitability. Institutional investor participation has decreased, and the stock has underperformed major indices over multiple time horizons. Despite some growth in operating profit, the overall financial and market context remains subdued.
The stock’s recent performance and financial metrics provide a detailed picture of the challenges faced by Mukka Proteins Ltd within the FMCG sector, highlighting the severity of its current position in the market.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
